Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Character | Response | |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class | Active | Resistant |
---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
Lineage | Physiology | General | Growth Tolerances | Hydrol./digest./degr. |
|
|
Health: Unknown
Source: molluscs, water, soil, clinical sources (blood, wounds, bile) and human faeces (Alkhalil2017- ulcerative colitis patient)
|
Opt. T: 30-37℃
|
|
---|
Monosaccharide O/F | Oligosaccharide O/F | Polysaccharide O/F | Polyol O/F | Other O/F |
|
|
|
|
|
---|
Monosaccharide util/assim | Oligosaccharide util/assim | Other carboh. util/assim | Amino acid util/assim | Organic acid util/assim |
|
|
|
|
|
---|
Enzymes: General | Enzymes: Carbohydrate | Enzymes: Protein | Enzymes: Arylamidases | Enzymes: Esters/fats |
|
|
|
|
|
---|
Fuel | Usable Metabolites | Metabolites Released | Special Products | Compounds Produced |
|
---|
Penicillins & Penems (μg/mL) | Cephalosporins (μg/mL) | Aminoglycosides (μg/mL) | Macrolides (μg/mL) | Quinolones (μg/mL) |
piper-taz: S(≤1/4)
ertapenem: S(≤0.125/≤0.125)
imipenem: S(0.25/2)
|
ceftazidime: S(≤0.5/≤0.5)
|
amikacin: S(MIC50): ≤2, MIC90: ≤2, RNG: (0.25->32)
gentamicin: S(≤2/≤2)
|
|
ciprofloxacin: S(≤0.5/≤0.5)
levofloxacin: S(≤0.5/≤0.5)
moxifloxacin: S(≤0.5/1)
|
---|---|---|---|---|
Tetracyclines (μg/mL) | Vancomycin Class (μg/mL) | Polypep/ketides (μg/mL) | Heterocycles (μg/mL) | Other (μg/mL) |
|
|
|
|
|